Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: environmental factors, molecular profile and drug/nanotherapeutic approaches

M Ashrafizadeh, K Luo, W Zhang, AR Aref… - Environmental research, 2024 - Elsevier
A high number of cancer patients around the world rely on gemcitabine (GEM) for
chemotherapy. During local metastasis of cancers, surgery is beneficial for therapy, but …

Recent update and drug target in molecular and pharmacological insights into autophagy modulation in cancer treatment and future progress

MA Rahman, ASM Saikat, MS Rahman, M Islam… - Cells, 2023 - mdpi.com
Recent evidence suggests that autophagy is a governed catabolic framework enabling the
recycling of nutrients from injured organelles and other cellular constituents via a lysosomal …

[HTML][HTML] A bioinformatics analysis, pre-clinical and clinical conception of autophagy in pancreatic cancer: complexity and simplicity in crosstalk

M Ashrafizadeh, W Zhang, R Zou, G Sethi… - Pharmacological …, 2023 - Elsevier
Pancreatic cancer (PC) is a serious gastrointestinal tract disease for which the 5-year
survival rate is less than 10%, even in developed countries such as the USA. The genomic …

The role of metabolic reprogramming in pancreatic cancer chemoresistance

C Liu, C Li, Y Liu - Frontiers in Pharmacology, 2023 - frontiersin.org
Pancreatic cancer is characterized by hidden onset, high malignancy, and early metastasis.
Although a few cases meet the surgical indications, chemotherapy remains the primary …

MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway

S Wei, Y Zhang, X Ma, Y Yao, Q Zhou, W Zhang… - Scientific Reports, 2023 - nature.com
Triple-negative breast cancer (TNBC), a highly aggressive and heterogeneous subtype of
breast cancer, lacks effective treatment options. Sophora flavescens Aiton, a Chinese …

[HTML][HTML] Promotion of ROS-mediated apoptosis, G2/M arrest, and autophagy by naringenin in non-small cell lung cancer

TM Chang, MC Chi, YC Chiang, CM Lin… - … Journal of Biological …, 2024 - ncbi.nlm.nih.gov
Background: As lung cancer is the leading cause of cancer death worldwide, the
development of new medicines is a crucial endeavor. Naringenin, a flavanone derivative …

Phyllanthus emblica L. extract alleviates leptin resistance and lipid accumulation by inhibiting methylglyoxal production

YN Huang, SY Chen, JA Lin, IC Chiang, GC Yen - Food Bioscience, 2023 - Elsevier
Increasing leptin resistance and methylglyoxal (MG) levels have been observed in patients
with obesity, which is characterized by an imbalance in energy metabolism and abnormal fat …

CircLMTK2 Silencing Attenuates Gemcitabine Resistance in Pancreatic Cancer by Sponging miR‐485‐5p and to Target PAK1

Y Lu, S Zhou, G Cheng, Y Ruan, Y Tian, K Lv… - Journal of …, 2022 - Wiley Online Library
Pancreatic cancer (PC) has a high degree of malignancy and poor prognosis, and countless
patients have distant metastasis when diagnosed. Gemcitabine (GEM) chemotherapy is one …

Heme Oxygenase-1 Inhibition Modulates Autophagy and Augments Arsenic Trioxide Cytotoxicity in Pancreatic Cancer Cells

IM Ahmad, AJ Dafferner, RJ Salloom, MY Abdalla - Biomedicines, 2023 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) is the most prevalent form, accounting for more
than 90% of all pancreatic malignancies. In a previous study, we found that hypoxia and …

HMGB1/RAGE axis in tumor development: unraveling its significance

A Fan, M Gao, X Tang, M Jiao, C Wang, Y Wei… - Frontiers in …, 2024 - frontiersin.org
High mobility group protein 1 (HMGB1) plays a complex role in tumor biology. When
released into the extracellular space, it binds to the receptor for advanced glycation end …